rs7903146 increases the risk of hypertension in patients with T2D; TCF7L2 variants increase glycemic indexes and T2D risk in MetS patients (Katsoulis et al., 2018; Phillips et al., 2012; Rattanatham et al., 2017). Here, TCF7L2 is linked to metabolic syndrome.